Thursday November 26 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Applera Corporation

Our mission is to improve human health and society by understanding and applying the power of biology to develop breakthrough research technologies and diagnostic products.Applera Corporation consists of two business groups -- the Applied Biosystems group and the Celera Genomics group. The Applied Biosystems Group (NYSE: ABI) serves the life science industry and research community by developing and marketing instrument-based systems, consumables, software, and services. Customers use these tools to analyze nucleic acids (DNA and RNA), small molecules, and proteins to make scientific discoveries and develop new pharmaceuticals. Applied Biosystems’ products also serve the needs of some markets outside of life science research, which we refer to as “applied markets,” such as the fields of: human identity testing (forensic and paternity testing); biosecurity, which refers to products needed in response to the threat of biological terrorism and other malicious, accidental, and natural biological dangers; and quality and safety testing, for example in food and the environment.


Contact Details:
301 Merritt 7P.O. Box 5435
Norwalk
Connecticut
06856-5435
United States of America
Tel:1 203-840-2000
Fax:1 800-761-5381
Email:
WWW:

www.pecorporation.com/




Loading...

Recent Publications by Applera Corporation:

Setting up a 2D-LC/MS/MS method for the rapid quantitation of the prostanoid metabolites 6-oxo-PGF(1alpha) and TXB2 as markers for hemostasis assessment.
6-oxo-PGF(1alpha) and TXB(2) are the metabolites of the prostanglandin...
19th August, 2009
Applied Biosystems, Applera Italia, Monza, Italy. J Mass Spectrom. 2009 Mar;44(3):346-52.
DOI Direct Link
Detection of protein-RNA crosslinks by NanoLC-ESI-MS/MS using precursor ion scanning and multiple reaction monitoring (MRM) experiments.
Protein-RNA interactions within ribonucleoprotein particles (RNPs) can be...
6th June, 2007
Applera Deutschland GmbH, Darmstadt, Germany. J Am Soc Mass Spectrom. 2007 May;18(5):869-81. Epub 2007 Mar 8.
DOI Direct Link
Rapid amplification of cDNA ends.
Protein-RNA interactions within ribonucleoprotein particles (RNPs) can be...
3rd December, 2003
CELERA, an Applera Corporation Business, Rockville, MD, USA. Methods Mol Biol. 2003;226:105-16.
DOI Direct Link

Press Releases on Applera Corporation:

BioPortfolio Logo
New Report Just Published: World Prostate Cancer Therapeutics Market Report 7th July, 2009 Reportlinker
NEW YORK, July 7 /PRNewswire/ -- Reportlinker.com just added a new market research report to its catalogue. World Prostate Cancer Therapeutics Market http://www.reportlinker.com/p0119471/World
Microtest Labs Doubles Microbial Identification, Analytical Services 3rd June, 2008 Microtest Laboratories
AGAWAM, Mass., June 3 /PRNewswire/ -- Microtest Laboratories (http://www.microtestlabs.com) has doubled their microbial identification and analytical services with the purchase of an additional
PETER LUNDBERG JOINS SOLEXA AS VP AND CHIEF TECHNICAL OFFICER 1st January, 1970 Solexa
PETER LUNDBERG JOINS SOLEXA AS VP AND CHIEF TECHNICAL OFFICER Company Builds Management Team to be a Future Genomics Platform Leader CAMBRIDGE, U.K. and

BioNews Results for Applera Corporation:

Research and Markets: Drug Discovery Technologies - A Global Update of Market Trends & Opportunities
SmartBrief:  Nov 19 2009 2:58AM Matching: applera
Research and Markets: Drug Discovery Technologies - A Global Update of Market Trends & Opportunities
Forbes.com:  Nov 18 2009 3:32PM Matching: applera
Research and Markets: Drug Discovery Technologies - A Global Update of Market Trends & Opportunities
Business Wire UK:  Nov 18 2009 3:12PM Matching: applera
Stock research report available on Celera (NYSE:CRA) from SmarTre...
Zibb:  Nov 11 2009 2:00AM Matching: applera
Life Tech Drops Challenge to Proteome Sciences European Patent for TMT Technology
GenomeWeb:  Oct 30 2009 3:43PM Matching: applera
Promote your company here: BioNewsCast - Press Release Distribution

View more Applera Corporation news.

Applera Corporation Patents:

US Patent No.Title
7381571 Device and method for analyte detection
7399645 Constrained cis-diol-borate bioconjugation system
7399854 Regents labeled with energy transfer dyes
7402671 UV excitable fluorescent energy transfer dyes
7405396 Sample handling mechanisms and methods for mass spectrometry

View more Applera Corporation patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 365 times since April 2007, the link to the organisation's website has been followed 71 times

Recent Search Terms used to find this page: APPLERA CORPORATION | APPLERA CORPORATION | APPLERA CORPORATION 2009 | .

Search for more companies in Norwalk

Search for more companies in Connecticut



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Applera Corporation

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.